Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA)

The European Medicines Agency (EMA) has approved five pandemic COVID-19 vaccines (prior to April 2022) and many others are in the pipeline. The commentary describes how timely approval and rapid manufacturing capacity scale up could be achieved from our perspective. The commentary considers the need...

Descripción completa

Detalles Bibliográficos
Autores principales: Shivji, Ragini, Conocchia, Roberto, Korakianiti, Evdokia, Jekerle, Veronika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226196/
https://www.ncbi.nlm.nih.gov/pubmed/35779964
http://dx.doi.org/10.1016/j.vaccine.2022.06.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226196/
https://www.ncbi.nlm.nih.gov/pubmed/35779964
http://dx.doi.org/10.1016/j.vaccine.2022.06.058

Ejemplares similares